Diaphragm ultrasound to evaluate the antagonistic effect of sugammadex on rocuronium after liver surgery in patients with different liver Child-Pugh grades: study protocol for a prospective, double-blind, non-randomised controlled trial

Shujun Sun, Yan Sun, Rui Chen, Chunlin Yao, Haifa Xia, Xiangdong Chen, Yun Lin, Shanglong Yao, Shujun Sun, Yan Sun, Rui Chen, Chunlin Yao, Haifa Xia, Xiangdong Chen, Yun Lin, Shanglong Yao

Abstract

Introduction: The use of muscle relaxants is an indispensable in the general anaesthesia but is prone to accidents, which are often related to residual muscle relaxant. Therefore, how to timely and effectively eliminate the residual effect of muscle relaxants after surgery has become an urgent clinical problem. Rocuronium is a non-depolarising muscle relaxant that is primarily metabolised by the liver. Patients with liver dysfunction can affect the metabolic process of rocuronium, thereby delaying the recovery of muscle relaxation. Sugammadex (SUG) is a novel-specific antagonist of aminosteroidal muscle relaxants, which can effectively antagonise muscle relaxants at different depths. However, whether liver dysfunction affects the antagonistic effect of SUG against rocuronium has not been reported. Therefore, we hypothesise that with the increase of patients' liver Child-Pugh grade, the recovery time of rocuronium antagonised by the same dose of SUG after surgery will be prolonged, and the incidence of muscle relaxation residual will be increased in the short term.

Methods and analysis: This study is a prospective, double-blind, low-intervention, non-randomised controlled clinical trial involving 99 patients with American Society of Anesthesiologists (ASA) Ⅰ-Ⅲ, body mass index 18.5-24.9 kg/m2, who will undergo laparoscopic radical resection of liver cancer under general anaesthesia in the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Ultrasonography will be applied to monitor the change rate of diaphragm thickness at different time after extubation to evaluate the occurrence of residual muscle relaxant, which indirectly reflects the dose-effect relationship of SUG antagonising against rocuronium in patients with different liver Child-Pugh grades preoperatively.

Ethics and dissemination: The protocol was reviewed and approved by the Medical Ethics Committee of Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology (UHCT21012). The findings will be disseminated to the public through peer-reviewed scientific journals.

Trial registration number: NCT05028088.

Keywords: adult anaesthesia; hepatobiliary surgery; ultrasonography.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Images of the diaphragm ultrasound. THI, Tissue Harmonic Imaging.
Figure 2
Figure 2
Study flow diagram. PACU, postanaesthesia care unit; TOF, train of four.
Figure 3
Figure 3
Study data acquisition table. ΔDF, diaphragmatic baseline recovery fraction; DTF, diaphragmatic thickness fraction; PACU, post-anesthesia care unit; SUG, Sugammandex; TEE, thickness at the end of expirations; TEI, thickness at the end of inspirations.

References

    1. Whittaker R, Wedell D. Review of neuromuscular blockers. Compendium 1991;12:408–10.
    1. Naguib M, Magboul MM. Adverse effects of neuromuscular blockers and their antagonists. Drug Saf 1998;18:99–116. 10.2165/00002018-199818020-00002
    1. Ariño-Irujo JJ, Calbet-Mañueco A, De la Calle-Elguezabal PA, et al. . [Neuromuscular blockade monitoring. Part 1]. Rev Esp Anestesiol Reanim 2010;57:153–60. 10.1016/s0034-9356(10)70190-0
    1. Fuchs-Buder T, Schmartz D. [Residual neuromuscular blockade]. Anaesthesist 2017;66:465–76. 10.1007/s00101-017-0325-1
    1. Brull SJ, Kopman AF. Current status of neuromuscular reversal and monitoring: challenges and opportunities. Anesthesiology 2017;126:173–90. 10.1097/ALN.0000000000001409
    1. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010;111:120–8. 10.1213/ANE.0b013e3181da832d
    1. Aytac I, Postaci A, Aytac B. Survey of postoperative residual curarization, acute respiratory events and approach of anesthesiologists. Braz J Anesthesiol 2016;66:55–62. 10.1016/j.bjane.2012.06.011
    1. Shaydenfish D, Wongtangman K, Eikermann M, et al. . The effects of acetylcholinesterase inhibitors on morbidity after general anesthesia and surgery. Neuropharmacology 2020;173:108134. 10.1016/j.neuropharm.2020.108134
    1. Hawkins J, Khanna S, Argalious M. Sugammadex for reversal of neuromuscular blockade: uses and limitations. Curr Pharm Des 2019;25:2140–8. 10.2174/1381612825666190704101145
    1. Tao J, Zhang W, Yue H, et al. . Prevalence of hepatitis B virus infection in Shenzhen, China, 2015–2018. Sci Rep 2019;9:13948. 10.1038/s41598-019-50173-5
    1. Zou L, Zhang W, Ruan S. Modeling the transmission dynamics and control of hepatitis B virus in China. J Theor Biol 2010;262:330–8. 10.1016/j.jtbi.2009.09.035
    1. Turhanoğlu S, Tunç M, Okşar M, et al. . Perioperative effects of induction with high-dose rocuronium during laparoscopic cholecystectomy. Turk J Anaesthesiol Reanim 2020;48:188–95. 10.5152/TJAR.2019.31855
    1. Yue GG-L, Chan K-M, To M-H, et al. . Potent airway smooth muscle relaxant effect of cynatratoside B, a steroidal glycoside isolated from Cynanchum stauntonii. J Nat Prod 2014;77:1074–7. 10.1021/np4008969
    1. van Miert MM, Eastwood NB, Boyd AH, et al. . The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Clin Pharmacol 1997;44:139–44. 10.1046/j.1365-2125.1997.00653.x
    1. Magorian T, Wood P, Caldwell J, et al. . The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg 1995;80:754–9. 10.1097/00000539-199504000-00018
    1. Parasa M, Vemuri NN, Shaik MS. Comparison of equipotent doses of rocuronium and vecuronium. Anesth Essays Res 2015;9:88–91. 10.4103/0259-1162.150676
    1. Abdulatif M, Lotfy M, Mousa M, et al. . Sugammadex antagonism of rocuronium-induced neuromuscular blockade in patients with liver cirrhosis undergoing liver resection: a randomized controlled study. Minerva Anestesiol 2018;84:929–37. 10.23736/S0375-9393.18.12217-6
    1. Keating GM. Sugammadex: a review of neuromuscular blockade reversal. Drugs 2016;76:1041–52. 10.1007/s40265-016-0604-1
    1. Ledowski T, O'Dea B, Meyerkort L, et al. . Postoperative residual neuromuscular paralysis at an Australian tertiary children's Hospital. Anesthesiol Res Pract 2015;2015:410248. 10.1155/2015/410248
    1. Cappellini I, Picciafuochi F, Ostento D, et al. . Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial. Trials 2018;19:135. 10.1186/s13063-018-2525-7
    1. Cappellini I, Ostento D, Loriga B, et al. . Comparison of neostigmine vs. sugammadex for recovery of muscle function after neuromuscular block by means of diaphragm ultrasonography in microlaryngeal surgery: a randomised controlled trial. Eur J Anaesthesiol 2020;37:44–51. 10.1097/EJA.0000000000001055
    1. Fried AM, Cosgrove DO, Nassiri DK, et al. . The diaphragmatic echo complex: an in vitro study. Invest Radiol 1985;20:62–7. 10.1097/00004424-198501000-00016
    1. Sarwal A, Walker FO, Cartwright MS. Neuromuscular ultrasound for evaluation of the diaphragm. Muscle Nerve 2013;47:319–29. 10.1002/mus.23671
    1. Fayssoil A, Behin A, Ogna A, et al. . Diaphragm: pathophysiology and ultrasound imaging in neuromuscular disorders. J Neuromuscul Dis 2018;5:1–10. 10.3233/JND-170276
    1. Ueki J, De Bruin PF, Pride NB. In vivo assessment of diaphragm contraction by ultrasound in normal subjects. Thorax 1995;50:1157–61. 10.1136/thx.50.11.1157
    1. Chan A-W, Tetzlaff JM, Gøtzsche PC, et al. . Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586. 10.1136/bmj.e7586
    1. Vivier E, Mekontso Dessap A, Dimassi S, et al. . Diaphragm ultrasonography to estimate the work of breathing during non-invasive ventilation. Intensive Care Med 2012;38:796–803. 10.1007/s00134-012-2547-7
    1. DiNino E, Gartman EJ, Sethi JM, et al. . Diaphragm ultrasound as a predictor of successful extubation from mechanical ventilation. Thorax 2014;69:431–5. 10.1136/thoraxjnl-2013-204111

Source: PubMed

3
Abonnieren